Nano Drug Delivery Systems for Colon Cancer

Dr. Vipan Kumar is an Associate Professor at the School of Pharmaceutical Sciences, CGC University, Mohali, India. He received his PhD in Pharmaceutical Sciences from Maharshi Dayanand University, Rohtak. His research focuses on medicinal chemistry, nanotechnology-based drug delivery, and the development of novel therapeutic agents for cancer and metabolic disorders. He has published extensively in peer-reviewed journals, authored and edited several books and international volumes, including Elsevier publications, and contributed book chapters. He also holds multiple Indian patents in drug discovery and nanomedicine. He serves as an editorial board member and reviewer for international journals, delivers several talks and poster presentations at conferences, and is actively involved in CCSEA-related ethical committees and university Boards of Studies.

Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana. She earned a Master’s from NIPER Mohali and a PhD from IIT-BHU Varanasi, focusing on medicinal chemistry and CNS drug delivery targeting serotonin receptors. Her research encompasses targeted therapies such as JAK-STAT inhibitors, signaling pathways in health and disease, synthetic and heterocyclic chemistry, nanotechnology-enabled drug delivery, prodrug design, and herbal drug extraction. She has published extensively, holds multiple patents, and contributed to and edited scholarly books and chapters. An active presence at national and international conferences, she has secured competitive grants from major funding agencies. Dr. Dhanawat's work advances pharmaceutical science and education, reflecting a strong commitment to innovation, mentorship, and translational research.